Replenix
Replenix, licence 80087952: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Dermaflash: Dermaprotect Daily Defense Broad Spectrum SPF 50, Replenix Ulti-Matte Tinted Physical Sunscreen SPF 50
- Licence holder
- Topix Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80087952
- Status
- Active licence
- Licence date
- 22 August 2018
- Revision date
- 19 December 2019
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Oxyde de zinc Source : Oxyde de zinc | 16.2 % | Not calculated |
Non-medicinal ingredients
Biotine, Méthyl triméthicone, Dimethyl silylate de silica, Resvératrol, Polymère croisé de diméthicone, Phospholipides, Acide poly(hydroxystéarique), Cyclopentasiloxane, Extrait de Centella asiatica, Cétyl PEG/PPG-10/1 Diméthicone, Céramide 2, Filtrat de fermentation de racine de radis par la bactérie Leuconostoc, Oxydes de fer, Eau purifiée, Isostéarate de glycéryle, Acétate de dl-alpha tocophéryle, Cyclotetrasiloxane, PEG/PPG-18/18 diméthicone, Diheptanoate de néopentylglycol, Acide L-ascorbique, Dioxyde de titane, Extrait de fruits de Phyllanthus Emblica, Coenzyme Q10, Silice pyrogénée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Nourrissons | minimum: 6.0 Mois ; maximum: 12.0 Mois | Not specified | Not specified |
| Adultes | minimum: 18.0 Année(s) | Not specified | Not specified |
| Adolescentes | minimum: 12.0 Année(s) ; maximum: 17.0 Année(s) | Not specified | Not specified |
| Enfants | minimum: 1.0 Année(s) ; maximum: 11.0 Année(s) | Not specified | Not specified |
Uses authorised in Canada
Absorbs throughout the UVA/UVB spectrum to provide sunburn protection. Broad spectrum (Sun Protection Factor "X" / SPF "X"). Filters/Screens UVA/UVB rays. Helps prevent sunburn. Helps protect from sunburn. If used as directed with other sun protection measures [see Directions (for Use)], decreases the risk of skin cancer and early skin aging caused by the sun. Sunburn protectant. Sun Protection Factor "X" / SPF "X". Sunscreen. UVA/UVB protection.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087952
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.